DC
Dan Chaplin
Investor at Bondaval
London, England
Overview
Dan Chaplin is a Partner at Dawn Capital in London, with a strong track record of successful investments in companies like Omi and Cover Genius. He has held key roles as an investor and board director in various successful ventures, demonstrating expertise in Enterprise and FinTech sectors.
Dan's career highlights include leading investments in Omi during its Series A stage and Cover Genius during its Series E stage, showcasing his ability to identify and support high-growth companies at different stages of development.
Work Experience
Partner
2018 - Current
Dawn is Europe's largest specialist B2B software VC. Supporting founders building the next generation of global software leaders. Investments include Access Fintech, Billie, Bondaval, Brite, Copper, Cover Genius, Elwood, Omi, OpenGamma, Tink [VISA]
Investor and Board Director
2024
Investor and Board Director
2023
Investor and Board Director
2022
Investor and Board Director
2022
Investor and Board Observer
2021
Investor and Board Observer
2021
Investor and Board Observer
2022
Angel Investor
2021
Lindus Health is a next-gen CRO running clinical trials for the health and biotech sectors.
Raised $24,545,079.00 from Seedcamp, Peter Thiel, Page One Ventures, Salica, Calm/Storm Ventures, Amino Collective, Firstminute Capital and Creandum.
Investor
2020
AccessFintech offers risk management services for banks and buyside firms and tracks the trade lifecycle.
Raised $97,500,000.00 from Goldman Sachs, BNP Paribas Securities Services, Citi, Dawn Capital, Bank of America, JP Morgan, BNY, GS Growth and WestCap.